Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Blood (2022) 139 (3): 384–398.

https://doi.org/10.1182/blood.2020010039

Published: 2022

Includes: Supplemental data

Journal Articles

Integrative Study of a High-Grade B-Cell Lymphoma Cohort of 45 Patients: A Single Institution Real Life Study

Louise Roulin, Elsa Poullot, Paul Blanc-Durand, Cyrielle Robe, Francois Lemonnier, Fabien Le Bras, Romain Gounot, Karim Belhadj, Jehan Dupuis, Mohammad Hammoud, Taoufik El Gnaoui, Sebastien Mule, Christiane Copie Bergman, Thierry Molina, Marie Helene Delfau Larue, Emmanuel Itti, Philippe Gaulard, Corinne Haioun

Blood (2021) 138 (Supplement 1): 4576.

https://doi.org/10.1182/blood-2021-152627

Published: 2021

Journal Articles

Real Time Pathological and Molecular Characterization of Aggressive B-Cell Lymphomas Based on a National Network. a Lysa Project

Christiane Copie Bergman, MDPhD, Elodie Bohers, PhD, Peggy Dartigues-Cuillères, MD, Pierre-Julien Viailly, Philippe Ruminy, PhD, Vinciane Marchand, Marie-Helene Delfau-Larue, Corinne Haioun, MDPhD, Cyrielle Robe, Elsa Poullot, MD, Steven Le Gouill, MD PhD, Yannick Le Bris, PharmD, Céline Bossard, MD, Anne Moreau, MD, Vincent Ribrag, MD, Valérie Camara-clayette, PhD, Cyril Quivoron, PhD, Gilles Salles, MDPhD, Sophie Cotteret, MD PhD, Pierre Sujobert, MD PhD, Alexandra Traverse-Glehen, MD PhD, Claire Mauduit, Pascaline Etancelin, Sarah Huet, Liana Veresezan, MD, Krimo Bouabdallah, MD, Marie Parrens, MD, Audrey Gros, PhD, Samuel Amintas, David Sibon, MD PhD, Ludovic Lhermitte, MD PhD, Thomas Steimle, Sophie Kaltenbach, Bettina Fabiani, MD, Camille Laurent, MD PhD, Barbara Burroni, Laurent Martin, MD PhD, Thierry Jo Molina, MDPhD, Lysa LYSARC study group, Fabrice Jardin, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141953

Published: 2020

Journal Articles

Mutational Landscape of Grey Zone Lymphoma

Blood (2019) 134 (Supplement_1): 21.

https://doi.org/10.1182/blood-2019-127375

Published: 2019

Journal Articles

Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma

Victor Bobée, PharmD, Fanny Drieux, MD, Vinciane Marchand, Vincent Sater, Liana Veresezan, MD, Jean-Michel Picquenot, MD, Pierre-Julien Viailly, Marie-delphine Lanic, Mathieu Viennot, Elodie Bohers, PhD, Lucie Oberic, MD, Christiane Copie-Bergman, MD PhD, Thierry Jo Molina, MD PhD, Philippe Gaulard, MD PhD, Corinne Haioun, MD PhD, Gilles A. Salles, MD PhD, Herve Tilly, MD PhD, Fabrice Jardin, Philippe Ruminy, PhD

Blood (2019) 134 (Supplement_1): 1476.

https://doi.org/10.1182/blood-2019-122405

Published: 2019

Journal Articles

Double-hit DLBCL: should we limit FISH testing?

Christiane Copie-Bergman

Blood (2018) 131 (18): 1997–1998.

https://doi.org/10.1182/blood-2018-03-836361

Published: 2018

Journal Articles

Integrated Analysis of IGHV Gene Status, Cell-of-Origin Signature and Genomic Features in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 4118.

https://doi.org/10.1182/blood.V128.22.4118.4118

Published: 2016

Journal Articles

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and Non-L265P Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Blood (2016) 128 (22): 4097.

https://doi.org/10.1182/blood.V128.22.4097.4097

Published: 2016

Journal Articles

Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study

Blood (2015) 126 (23): 1472.

https://doi.org/10.1182/blood.V126.23.1472.1472

Published: 2015

Journal Articles

Number of Circulating t(14;18) Tumor Cells at Diagnosis Is Related to, but Add to the Prognostic Value of Metabolic Tumor Burden in Follicular Lymphoma

Marie-Helene Delfau-Larue, MD PhD, Isabelle Nel, PD, Axel VAN Der Gucht, MD, Gaelle Laboure, MD, Benjamin Verret, MD, Salma Hamdane, PD, Philippe Gaulard, MD PhD, Michel Meignan, MD PhD, Corinne Haioun, MD PhD, Christiane Copie-Bergman, MD PhD, Jehan Dupuis, MD, Emmanuel Itti, MD PhD

Blood (2015) 126 (23): 3872.

https://doi.org/10.1182/blood.V126.23.3872.3872

Published: 2015

Journal Articles

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

Fabrice Jardin, MD PhD, Anais Pujals, PhD, Laura Pelletier, PhD, Elodie Bohers, PhD, Vincent Camus, Sylvain Mareschal, Sydney Dubois, Marlène Ochman, MD, Francois Lemonnier, MD, Pierre-Julien Viailly, Philippe Bertrand, PhD, Catherine Maingonnat, Alexandra Traverse-Glehen, Philippe Gaulard, MD PhD, Diane Damotte, MD PhD, Richard Delarue, MD, Corinne Haioun, MD PhD, Yosef Landesman, PhD, William Senapedis, PhD, Christian Argueta, PhD, Gilles Andre Salles, MD PhD, Jean-Philippe Jais, MD PhD, Martin Figeac, PhD, Christiane Copie-Bergman, MD PhD, Thierry Molina, Jean-Michel Picquenot, PhD, Marie Cornic, Thierry Fest, MD PhD, Noel Milpied, Emilie Lemasle, MD, Aspasia Stamatoullas, MD, Peter Moeller, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Christer Sundstrom, MD PhD, Christian Bastard, MD PhD, Hervé Tilly, MD PhD, Karen Leroy, MD PhD

Blood (2015) 126 (23): 129.

https://doi.org/10.1182/blood.V126.23.129.129

Published: 2015

Journal Articles

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Blood (2015) 126 (22): 2466–2474.

https://doi.org/10.1182/blood-2015-05-647602

Published: 2015

Includes: Supplemental data

Journal Articles

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract

Anamarija M. Perry, Roger A. Warnke, Qinglong Hu, Philippe Gaulard, Christiane Copie-Bergman, Serhan Alkan, Huan-You Wang, Jason X. Cheng, Chris M. Bacon, Jan Delabie, Erik Ranheim, Can Kucuk, XiaoZhou Hu, Dennis D. Weisenburger, Elaine S. Jaffe, Wing C. Chan

Blood (2013) 122 (22): 3599–3606.

https://doi.org/10.1182/blood-2013-07-512830

Published: 2013

Includes: Supplemental data

Journal Articles

BCL2 Negative Follicular Lymphoma with BCL6 Gene Rearrangement Show Mutations of STAT6 DNA Binding Domain

Marlene Ochmann, Christiane Copie-Bergman, Maryse Baia, Philippe Ruminy, Christian Bastard, MD, Corinne Haioun, MD, PhD, Philippe Gaulard, MD, Fabrice Jardin, MD, PhD, Karen Leroy, MD

Blood (2012) 120 (21): 1559.

https://doi.org/10.1182/blood.V120.21.1559.1559

Published: 2012

Journal Articles

Integrated Analysis of High-Resolution Gene Expression and Copy Number Profiling Identified Biallelic Deletion of CDKN2A/2B Tumor Suppressor Locus As the Most Frequent and Unique Genomic Abnormality in Diffuse Large B-Cell Lymphoma (DLBCL) with Strong Prognostic Value in Both GCB and ABC Subtypes and Not Overcome by a Dose-Intensive Immunochemotherapy Regimen Plus Rituximab. Results of a Prospective GELA Clinical Trial Program

Fabrice Jardin, MD, PhD, Sylvain Mareschal, Martin Figeac, PhD, Jean-Philippe Jais, MD, Karen Leroy, MD, Christiane Copie-Bergman, MD, Gilles Andre Salles, MD, PhD, Bertrand Coiffier, MD, Richard Delarue, MD, Frederic Peyrade, MD, Andre Bosly, MD, PhD, Nicolas Ketterer, MD, Corinne Haioun, MD, PhD, Herve Tilly, MD, Thierry Jo Molina, MD

Blood (2012) 120 (21): 415.

https://doi.org/10.1182/blood.V120.21.415.415

Published: 2012

Journal Articles

MYC Gene Simple Hit Is a Strong Independent Predictive Factor of Survival in Diffuse Large B-Cell Lymphomas in Contrast to MYC Double-Hit Gene Alterations: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte

Blood (2012) 120 (21): 541.

https://doi.org/10.1182/blood.V120.21.541.541

Published: 2012

Journal Articles

Expression of MYC, IgM, As Well As Non-Germinal Centre B-Cell Like Immunophenotype and Positive Immunofish Index Predict a Worse Progression Free Survival and Overall Survival in a Series of 670 De Novo Diffuse Large B-Cell Lymphomas Included in Clinical Trials: A GELA Study of the 2003 Program

Blood (2012) 120 (21): 1539.

https://doi.org/10.1182/blood.V120.21.1539.1539

Published: 2012

Journal Articles

R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B

Thierry Jo Molina, Danielle Canioni, Christiane Copie-Bergman, Christian Recher, MD, PhD, Marion Fournier, Corinne Haioun, Josette Briere, Francoise Berger, Christophe Fermé, Marie-Christine Copin, Rene-Olivier Casasnovas, Catherine Thieblemont, MD, Karen Leroy, Gilles Andre Salles, Fabrice Jardin, Jean-Philippe Jais, Philippe Gaulard, Bertrand Coiffier, Herve Tilly

Blood (2011) 118 (21): 2632.

https://doi.org/10.1182/blood.V118.21.2632.2632

Published: 2011

Journal Articles

Chlorambucil Plus Rituximab Produces Better Event-Free Survival in Comparison with Chlorambucil Alone in the Treatment of MALT Lymphoma: 5-Year Analysis of the 2-Arms Part of the IELSG-19 Randomized Study

Blood (2010) 116 (21): 432.

https://doi.org/10.1182/blood.V116.21.432.432

Published: 2010

Journal Articles

IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI

Philippe Chadebech, Marc Michel, Daniel Janvier, Kazunori Yamada, Christiane Copie-Bergman, Gwellaouen Bodivit, Armand Bensussan, Jean-Jacques Fournie, Bertrand Godeau, Philippe Bierling, Shozo Izui, France Noizat-Pirenne

Blood (2010) 116 (20): 4141–4147.

https://doi.org/10.1182/blood-2010-03-276162

Published: 2010

Includes: Supplemental data

NARROW

The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Integrative Study of a High-Grade B-Cell Lymphoma Cohort of 45 Patients: A Single Institution Real Life Study

Real Time Pathological and Molecular Characterization of Aggressive B-Cell Lymphomas Based on a National Network. a Lysa Project

Mutational Landscape of Grey Zone Lymphoma

Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma

Double-hit DLBCL: should we limit FISH testing?

Integrated Analysis of IGHV Gene Status, Cell-of-Origin Signature and Genomic Features in Diffuse Large B-Cell Lymphoma

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and Non-L265P Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study

Number of Circulating t(14;18) Tumor Cells at Diagnosis Is Related to, but Add to the Prognostic Value of Metabolic Tumor Burden in Follicular Lymphoma

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract

BCL2 Negative Follicular Lymphoma with BCL6 Gene Rearrangement Show Mutations of STAT6 DNA Binding Domain

MYC Gene Simple Hit Is a Strong Independent Predictive Factor of Survival in Diffuse Large B-Cell Lymphomas in Contrast to MYC Double-Hit Gene Alterations: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte

Expression of MYC, IgM, As Well As Non-Germinal Centre B-Cell Like Immunophenotype and Positive Immunofish Index Predict a Worse Progression Free Survival and Overall Survival in a Series of 670 De Novo Diffuse Large B-Cell Lymphomas Included in Clinical Trials: A GELA Study of the 2003 Program

R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B

Chlorambucil Plus Rituximab Produces Better Event-Free Survival in Comparison with Chlorambucil Alone in the Treatment of MALT Lymphoma: 5-Year Analysis of the 2-Arms Part of the IELSG-19 Randomized Study

IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only